- Home
- DVAX vs POWW Comparison
DVAX vs POWW Comparison
Compare DVAX & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVAX
- POWW
- Stock Information
- Founded
- DVAX 1996
- POWW 1990
- Country
- DVAX United States
- POWW United States
- Employees
- DVAX N/A
- POWW N/A
- Industry
- DVAX Biotechnology: Pharmaceutical Preparations
- POWW Ordnance And Accessories
- Sector
- DVAX Health Care
- POWW Industrials
- Exchange
- DVAX Nasdaq
- POWW Nasdaq
- Market Cap
- DVAX 1.3B
- POWW 167.5M
- IPO Year
- DVAX 2004
- POWW N/A
- Fundamental
- Price
- DVAX $9.36
- POWW $1.42
- Analyst Decision
- DVAX Buy
- POWW Buy
- Analyst Count
- DVAX 4
- POWW 2
- Target Price
- DVAX $26.50
- POWW $1.75
- AVG Volume (30 Days)
- DVAX 1.9M
- POWW 456.8K
- Earning Date
- DVAX 11-06-2025
- POWW 08-08-2025
- Dividend Yield
- DVAX N/A
- POWW N/A
- EPS Growth
- DVAX N/A
- POWW N/A
- EPS
- DVAX N/A
- POWW N/A
- Revenue
- DVAX $316,268,000.00
- POWW $45,280,898.00
- Revenue This Year
- DVAX $23.23
- POWW $8.25
- Revenue Next Year
- DVAX $16.57
- POWW $0.74
- P/E Ratio
- DVAX N/A
- POWW N/A
- Revenue Growth
- DVAX 26.66
- POWW 76.12
- 52 Week Low
- DVAX $9.21
- POWW $0.95
- 52 Week High
- DVAX $14.63
- POWW $2.14
- Technical
- Relative Strength Index (RSI)
- DVAX 32.99
- POWW 50.48
- Support Level
- DVAX $9.51
- POWW $1.41
- Resistance Level
- DVAX $9.94
- POWW $1.64
- Average True Range (ATR)
- DVAX 0.29
- POWW 0.08
- MACD
- DVAX -0.07
- POWW -0.00
- Stochastic Oscillator
- DVAX 12.31
- POWW 8.33
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
About POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.